Showing results (51-60 of 147) with videos related to
Sort By:
Pageof 15
Nature Communications|March 31, 2015
The nuclear translocation of ERK1/2 as an anticancer targetAlexander Plotnikov, Karen Flores, Galia Maik-Rachline, et al.Plos One|March 14, 2013
Development of allogeneic NK cell adoptive transfer therapy in metastatic melanoma patients: in vitro preclinical optimization studiesMichal J Besser, Tsipi Shoham, Orit Harari-Steinberg, et al.Journal of Immunology Research|December 22, 2015
Serum CEACAM1 Elevation Correlates with Melanoma Progression and Failure to Respond to Adoptive Cell Transfer ImmunotherapyR Ortenberg, S Sapoznik, D Zippel, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 6, 2016
Membrane-attached Cytokines Expressed by mRNA Electroporation Act as Potent T-Cell AdjuvantsHadas Weinstein-Marom, Aviad Pato, Noam Levin, et al.Anticancer Research|September 15, 2019
Tissue Harvesting for Adoptive Tumor Infiltrating Lymphocyte Therapy in Metastatic MelanomaDouglas Zippel, Orli Friedman-Eldar, Shlomi Rayman, et al.Oncotarget|December 17, 2017
Histopathological expression analysis of intercellular adhesion molecule 1 (ICAM-1) along development and progression of human melanomaGilli Galore-Haskel, Erez N Baruch, Amy L Berg, et al.BMJ Open|December 20, 2013
Urine C-peptide creatinine ratio can be used to assess insulin resistance and insulin production in people without diabetes: an observational studyRichard A Oram, Andrew Rawlingson, Beverley M Shields, et al.Oncoimmunology|November 20, 2019
Tumor-infiltrating lymphocytes from human prostate tumors reveal anti-tumor reactivity and potential for adoptive cell therapySharon Yunger, Assaf Bar El, Li-At Zeltzer, et al.Cancer Immunology, Immunotherapy : CII|November 17, 2020
microRNA expression patterns in tumor infiltrating lymphocytes are strongly associated with response to adoptive cell transfer therapyGilli Galore-Haskel, Eyal Greenberg, Inbal Yahav, et al.Science (New York, N.Y.)|July 30, 2021
Preventing type 1 diabetes in childhoodColin M Dayan, Rachel E J Besser, Richard A Oram, et al.Pageof 15